Taking back control – the post-pandemic landscape for life sciences regulation

Posted on | Analysis Life Sciences Yearbook 2024 |
Taking back control – the post-pandemic landscape for life sciences regulation

After years of delays caused by geopolitical instability and the Covid-19 pandemic, the new regulatory landscape for the life sciences industry is beginning to take shape in both the UK and the EU. As the UK pushes ahead with its post-Brexit journey of divergence, establishing itself as an innovation-friendly environment in the global life sciences …

Continue reading “Taking back control – the post-pandemic landscape for life sciences regulation”

Life Sciences perspectives: Grant Castle

Posted on | Analysis Life Sciences Yearbook 2024 |
Life Sciences perspectives: Grant Castle

Why did you decide to specialise in life sciences? I have a science background – a PhD in organic chemistry – and worked for a short time as a medicinal chemist for Glaxo. I also had an interest in the humanities at school, so law had always seemed to be an option, and life sciences …

Continue reading “Life Sciences perspectives: Grant Castle”

Rising stars: Zina Chatzidimitriadou – ‘It is the one legal area that affects every single one of us and is, above all, human-centred’

Posted on | Analysis Life Sciences Yearbook 2024 |
Rising stars: Zina Chatzidimitriadou – ‘It is the one legal area that affects every single one of us and is, above all, human-centred’

Zina Chatzidimitriadou, senior managing associate at Sidley, on why she picked a career in life sciences law Why did you decide to specialise in life sciences law? In 2009, in my previous life as a molecular biologist at the Cancer Research UK institute, I experienced the multiple issues and complexities facing researchers and people involved …

Continue reading “Rising stars: Zina Chatzidimitriadou – ‘It is the one legal area that affects every single one of us and is, above all, human-centred’”

Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’

Posted on | Analysis Life Sciences Yearbook 2024 |
Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’

Baker McKenzie’s Jaspreet Takhar on the future of digital health solutions What made you decide to specialise in life sciences law? I specialise in advising on digital health solutions – that means advising on the regulation of health data, digital health solutions (including AI solutions, software and medical devices), as well as contracting in this …

Continue reading “Rising stars: Jaspreet Takhar – ‘EU regulators are preparing an avalanche of new laws that are going to have a monumental impact on pharma and medtech’”

Rising stars: Dr Chris Boyle – ‘AI is going to have a transformative impact on the life sciences industry’

Posted on | Analysis Life Sciences Yearbook 2024 |
Rising stars: Dr Chris Boyle – ‘AI is going to have a transformative impact on the life sciences industry’

Dr Chris Boyle, counsel at Sidley, on the risks and opportunities facing the industry What do you most enjoy about being a life sciences lawyer? My passion for science led me to qualify and practice as a veterinary surgeon before I discovered that scientists and clinicians are uniquely placed to make a big impact in …

Continue reading “Rising stars: Dr Chris Boyle – ‘AI is going to have a transformative impact on the life sciences industry’”

Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’

Posted on | Analysis Life Sciences Yearbook 2024 |
Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’

David Gibson, senior associate at McDermott Will & Emery Why did you decide to specialise in life sciences law, and what’s the best thing about being a life sciences lawyer? I find the subject matter fascinating, and I am genuinely curious about new technologies and medicines and how they can be used, shared and applied …

Continue reading “Rising stars: David Gibson – ‘There are so many great new technologies and medicines with potential to make a difference to populations and treatment pathways but key challenges remain in regulating them’”

Euro Elite 2023: Nordics – New challenges

Posted on | Euro Elite 2023 International Nordics | and
Euro Elite 2023: Nordics – New challenges

In an increasingly tumultuous market, the Nordic region has thus far remained resilient to pressures; as the Covid-19 pandemic begins to abate, new stressors, such as the war in Ukraine and global economic downturn are starting to affect investment and deal flow across Norway, Sweden, Denmark and Finland. With the countries’ proximity to Russia, and …

Continue reading “Euro Elite 2023: Nordics – New challenges”